Boc-Lys(Z)-OSu CAS 34404-36-9 Puritas >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. est primarius opificem Boc-Lys(Z)-OSu (CAS: 34404-36-9) magna qualitate.Ruifu chemica seriem amino acida supplet.Praebere possumus terrarum traditionem, pretium competitive, quantitates parvas et parvas in promptu.Purchase Boc-Lys(Z)-OSu;Please contact: alvin@ruifuchem.com
Nomen chemicum | Boc-Lys(Z)-OSu |
Synonyma | Boc-Lys(Z)-OSu;Boc-L-Lys(Z)-OSu;Nα-Boc-Nε-Cbz-L-Lysine N-Hydroxysuccinimide Ester;Nα-Boc-Nε-ZL-Lysine Hydroxysuccinimide Ester;Nε-Z-Nα-Boc-L-Lysine Hydroxysuccinimide Ester;N-alpha-Boc-Nepsilon-ZL-Lysine N-Hydroxysuccinimide Ester;Nepsilon-Benzyloxycarbonyl-Nalpha-Boc-L-Lysine N-Succinimidyl Ester |
Stock Status | In Stock |
CAS Number | 34404-36-9 |
Formulae hypotheticae | C23H31N3O8 |
M. Pondus | 477.51 g/mol |
Liquescens punctum | 108.0~120.0℃ |
Density | 1.27 |
Aqua Solubility | Leviter solutum in aqua |
Repono Nativ. | Frigus & siccum (2~8℃) |
COA & MSDS | Praesto |
Categoria | Boc-Amino Acids |
Brand | Ruifu Chemical |
WGK Germania | 3 | HS Code* | 2922491990 |
F | 3-10-21 |
Items | Signa inspectionis | Proventus |
Aspectus | Alba pulveris | Alba pulveris |
Imprimis rotationis [α]20/D | -20.5°±3.0° (C=1 in Dioxane) | -22.44° |
Liquescens punctum | 108.0~120.℃ | 110.7℃ |
Damnum in Siccatio | <0.50% | 0.35% |
Puritas / Analysis Methodus | >98.0% (HPLC) | 98.45% |
Massa Imaginis | Secundum Latin | Obsequitur |
NMR Imaginum | Secundum Latin | Obsequitur |
conclusio | Productum probatum & obsequitur cum specificationibus |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Condite in vasis obsignatis apud frigus et siccum (2~8℃) horreum ab substantiis incompossibilibus.A luce et humore protege.
Naviportans:Libera ad orbem terrarum per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Annorum Usus?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Boc-Lys(Z)-OSu (CAS: 34404-36-9), Acidum Boc-aminum, synthesis peptidis adhibita, genus reactionis: "Boc solidae periodi peptidis synthesis.Adhibetur ut synthesis organica media, media pharmaceutica, biochemica reagens vel chemicus gerens.
Boc-Lys(Z)-OSu est reactant implicatum in labelingi cellulari et tumore MRI ut agentis antithesis bimodalis lipidicae, synthesis peptidis melioris prodrugum 5-ALA pro therapia photodynamica, Designatio altae affinitatis peptidis conjugatorum ut figunt pro vectore parvo peptidis PEPT1 (SLC15A1) Praeparatio incrementi humani derivationes hormonum continentium coetus PEG, Enantiodivergentis asymmetrica cyclizationis et solida-phasis synthesis coniugatorum peptide-cationicorum steroidei pro protegendo antibacterial.
Reactant involved in
· Designatio cellularis et tumor MRI ut agentis antithesis bimodalis lipidis
· Synthesis peptidis melioris prodrugum 5-ALA pro justo photodynamico
· Designatio altae affinitatis peptidis coniugatorum indicum pro vectore peptida parva PEPT1 (SLC15A1)
· Praeparatio incrementi humani derivationes hormonum continentes circulos PEG
· Enantiodivergent cyclization asymmetricae
· Synthesis solidae phases peptide-cationicae steroidis conjugatorum pro protegendo antibacterial